Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1560-1564, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Han, Q.
Right arrow Articles by Hoffman, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Han, Q.
Right arrow Articles by Hoffman, R. M.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Nutrition
(Clinical Chemistry. 2002;48:1560-1564.)
© 2002 American Association for Clinical Chemistry, Inc.

Homogeneous, Nonradioactive, Enzymatic Assay for Plasma Pyridoxal 5-Phosphate

Qinghong Han1, Mingxu Xu1, Li Tang1, Xuezhong Tan1, Xiuying Tan1, Yuying Tan1 and Robert M. Hoffmana1

1 A/C Diagnostics, 7917 Ostrow St., San Diego, CA 92111.

aAuthor for correspondence. Fax 858-268-4175; e-mail all{at}anticancer.com.

Background: Pyridoxal 5'-phosphate (PLP) is the biologically active form of vitamin B6. Clinical studies suggest that low PLP concentrations are an independent risk factor for cardiovascular and other diseases. However, PLP concentrations are not routinely diagnosed because of the lack of a homogeneous, nonradioactive assay. We describe a homogeneous, nonradioactive, enzymatic PLP assay that uses the apo form of the PLP-dependent recombinant enzyme, homocysteine-{alpha},{gamma}-lyase (rHCYase).

Methods: PLP was removed from holoenzyme rHCYase by incubation with hydroxylamine to obtain apo-rHCYase. The restoration of enzymatic activity by reconstitution of the holoenzyme was linearly related to the amount of PLP bound to the enzyme. The amplification principle of the assay allowed nanomolar concentrations of PLP to be measured by the conversion (by reconstituted holo-rHCYase) of millimolar concentrations of homocysteine to H2S. N,N-Dibutylphenylenediamine (DBPDA) was used for determination of H2S, the combination of which forms a chromophore with high absorbance. The assay was initiated by incubation of 5 µL of plasma with apo-rHCYase in a binding buffer for 60 min at 37 °C. Homocysteine (2.5 mmol/L) was added to the assay buffer and incubated at 37 °C for 20 min. The DBPDA reaction was allowed to progress for 10 min and then read at 675 nm.

Results: The PLP enzymatic assay has a lower limit of detection of 5 nmol/L and is linear to 200 nmol/L. The recovery of PLP was 98%. The mean within- and between-run CVs were 9.6% and 12%, respectively. Correlation of 45 samples in the PLP enzymatic assay and the B6 3H radioenzymatic assay (American Laboratory Products Co., Ltd.) yielded: y = 0.9367x + 10.569 (R2 = 0.9201).

Conclusions: This new PLP assay is the first homogeneous, nonradioactive, vitamin B6 diagnostic method. The assay is applicable to chemistry automated analyzers and may have wide clinical use.




The following articles in journals at HighWire Press have cited this article:


Home page
 Am. J. Clin. Nutr.Home page
M. S. Morris, M. F. Picciano, P. F Jacques, and J. Selhub
Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1446 - 1454.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. E. Rybak, R. B. Jain, and C. M. Pfeiffer
Clinical Vitamin B6 Analysis: An Interlaboratory Comparison of Pyridoxal 5'-Phosphate Measurements in Serum
Clin. Chem., July 1, 2005; 51(7): 1223 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Yang, X. Sun, S. Li, Y. Tan, X. Wang, N. Zhang, S. Yagi, T. Takakura, Y. Kobayashi, A. Takimoto, et al.
Circulating Half-Life of PEGylated Recombinant Methioninase Holoenzyme Is Highly Dose Dependent on Cofactor Pyridoxal-5'-Phosphate
Cancer Res., August 15, 2004; 64(16): 5775 - 5778.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
Q. Han, M. Xu, L. Tang, X. Sun, N. Zhang, X. Tan, X. Tan, Y. Tan, and R. M. Hoffman
Homogeneous Enzymatic Colorimetric Assay for Total Cysteine
Clin. Chem., July 1, 2004; 50(7): 1229 - 1231.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Sun, Z. Yang, S. Li, Y. Tan, N. Zhang, X. Wang, S. Yagi, T. Yoshioka, A. Takimoto, K. Mitsushima, et al.
In Vivo Efficacy of Recombinant Methioninase Is Enhanced by the Combination of Polyethylene Glycol Conjugation and Pyridoxal 5'-Phosphate Supplementation
Cancer Res., December 1, 2003; 63(23): 8377 - 8383.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.